Jeff Gautschi

Title: Jeff Gautschi: Innovator in Pharmaceutical Science

Introduction

Jeff Gautschi is a notable inventor based in Boulder, Colorado. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug formulations. His work focuses on enhancing the efficacy of treatments through advanced chemical compositions.

Latest Patents

Jeff Gautschi holds a patent for a solid dispersion of an ERB2 (HER2) inhibitor. This patent, which includes a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine, outlines processes for preparing the solid dispersion. Additionally, it describes a pharmaceutical composition that comprises this solid dispersion and its various uses.

Career Highlights

Jeff Gautschi is associated with Array Biopharma Inc., a company known for its focus on developing targeted therapies for cancer. His role at the company has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Jeff has collaborated with esteemed colleagues, including David Fry and Christopher M Lindemann. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jeff Gautschi's work exemplifies the spirit of innovation in pharmaceutical science. His contributions, particularly in the area of drug formulation, continue to impact the industry positively.